Ranbaxy’s generic lipitor (Atorvastatin) sales halted in Denmark


Pfizer reports that the sales of generic version of lipitor (marketed by Ranbaxy) in Denmark are halted after a Danish court granted a preliminary injunction in favour of Pfizer.

That is another blow for Ranbaxy, the India based multinational when it is going through the turmoil of
surprise FDA raids in its USA office. Now it looks as if the decision to go ahead before the court decision was taken in haste. If the final verdict comes in favour of Pfizer, Ranbaxy may have to payva huge compensation packet for the lost sales of Pfizer.

Pfizer’s news:
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product

2 comments:

  1. Peter Chen says

    Just dropping by to say thanks for leaving a comment in my post Smart Pricing and what you can do about it. I have responded to your comment.

    Peter a.k.a. enviroman
    Enviroman Says


    Seeji says

    Hi Peter,

    Thank you for visiting my blog. I will make the changes as per your suggestions and will get back to you later